Junshi Biosciences announces Toripalimab’s approval in Australia for cancer treatment

Shanghai Junshi Biosciences Co., and its wholly-owned subsidiary, TopAlliance Biosciences Inc. have announced that torip...

January 20, 2025 | Monday | News
Germany's BioMed X Institute launches new collaboration with Japanese firm Daiichi Sankyo in cancer therapy

BioMed X, an independent biomedical research institute based in Heidelberg, Germany, has announced the launch of a new c...

January 16, 2025 | Thursday | News
INTERPHEX 2025: Accelerating Pharma and Biotech Innovation at the Javits Center in NYC

Join thousands of industry professionals at INTERPHEX, the premier pharmaceutical and biotechnology event taking place A...

January 16, 2025 | Thursday | News
Australia's Telix Pharma buys next-gen therapeutic assets from ImaginAb

Australia-based Telix Pharmaceuticals has entered into an asset purchase agreement with US-based antibody engineering co...

January 13, 2025 | Monday | News
Vertex and Zai Lab enter into partnership to treat autoimmune diseases in China, Taiwan, Singapore

US-based Vertex Pharmaceuticals and China-based Zai Lab have announced an exclusive collaboration and license agreement ...

January 10, 2025 | Friday | News
Singapore launches industry-ready skill programs through interdisciplinary collaboration between academia, biopharma and the EDB

RP launched the Talent Advancement Programme (TAP), a first-of-its-kind initiative across local polytechnics...

January 9, 2025 | Thursday | News
Newron and Myung In Pharm join hands to improve schizophrenia treatment in South Korea

Italy headquartered Newron Pharmaceuticals S.p.A., a biopharmaceutical company focused on the development of novel thera...

January 10, 2025 | Friday | News
Switzerland’s Basel region emerges as top destination to launch Drug Device Company

New research released ahead of Pharmapack Europe (on January 22-23), the continent’s largest partnering event for ...

January 9, 2025 | Thursday | News
China approves GSK's Nucala for treatment of adults with chronic rhinosinusitis with nasal polyps

GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), a monoc...

January 7, 2025 | Tuesday | News
Japan's Kaken Pharma enters into license agreement for STAT6 inhibitor with Johnson & Johnson for $1.2 B

Japan-based Kaken Pharmaceutical Co. has entered into a license agreement with Johnson & Johnson for the globa...

January 7, 2025 | Tuesday | News
Japanese firms JCR Pharmaceuticals and Modalis Therapeutics move forward with development of novel gene therapy

JCR Pharmaceuticals Co. and Modalis Therapeutics Corporation have validated the initial proof of concept ...

January 6, 2025 | Monday | News
Pharmanovia signs in-licensing deal for novel osteoporosis treatment with Radius Health across key markets in APAC

Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises, extends and expands th...

January 5, 2025 | Sunday | News
Japan approves first and only facilitated subcutaneous immunoglobulin for Agammaglobulinemia and Hypogammaglobulinemia

Takeda has announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of HYQVIA [Immun...

January 5, 2025 | Sunday | News
China's Innovent Biologics enters into billion dollar oncology deal with Roche

China-based Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercial...

January 4, 2025 | Saturday | News
Businessperson of the year 2024- Dr Christian Behrenbruch (Telix Pharma)

Dr Christian Behrenbruch founded Telix Pharmaceuticals in 2015, along with Andreas Kluge, with an aim to create a truly ...

January 2, 2025 | Thursday | Analysis
Singapore Turns Tech Beacon with Revolutionary Pharma Manufacturing & Digital Transformation

Singapore has been viewed as a global hub in Asia for many years, and has strived to stay ahead of the curve when it com...

January 2, 2025 | Thursday | Opinion
Bio-Thera Solutions & Tabuk Pharma to commercialise Stelara (Ustekinumab) biosimilar in Saudi Arabia

China-based Bio-Thera Solutions Inc., a commercial-stage biopharmaceutical company developing a pipeline of innovat...

December 24, 2024 | Tuesday | News
Lakeside signs $1.5 M sales agreement with China's Sinopharm Group Subsidiary

Lakeside Holding, a US-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific&nb...

December 18, 2024 | Wednesday | News